Cationic Cyclodextrin-Based Carriers for Drug and Nucleic Acid Delivery
This review elaborates the recent developments in the cationic cyclodextrin-mediated delivery of drugs and nucleic acids. Cationic cyclodextrin-based delivery systems
A forum for researchers, students and applicants in the field of cyclodextrin technology
This review elaborates the recent developments in the cationic cyclodextrin-mediated delivery of drugs and nucleic acids. Cationic cyclodextrin-based delivery systems
📘 Cyclodextrins in Cancer Therapy (Published by Wiley)📗 Cyclodextrins in Environmental Remediation (Published by Springer Nature) These volumes aim to
This work establishes the design of a fully synthetic, shear-thinning hydrogel platform that is injectable and can isolate engineered, allogeneic
Here a new βCD-based nucleic acid delivery platform is proposed that surmounts the former archetype in its capacity to encode
This work establishes the design of a fully synthetic, shear-thinning hydrogel platform that is injectable and can isolate engineered, allogeneic
Gene therapy can be an efficient method to treat genetic diseases, including cancer. However, the lack of biocompatible gene delivery
Over the last decade, the clustered, regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) system has become the most
This Special Issue aims to showcase cutting-edge research, advancements, and applications of cyclodextrin-based delivery systems in the context of gene
Cyclodextrins have been widely employed for drug delivery systems (DDSs) in which drugs are selectively delivered to a target site
Professor Makoto Komiyama (born in 1947) is a world-famous nucleic acid chemist who is known for using artificial approaches to